Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,806 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.
Kanekiyo M, Matsuo K, Hamatake M, Hamano T, Ohsu T, Matsumoto S, Yamada T, Yamazaki S, Hasegawa A, Yamamoto N, Honda M. Kanekiyo M, et al. Among authors: matsumoto s. J Virol. 2005 Jul;79(14):8716-23. doi: 10.1128/JVI.79.14.8716-8723.2005. J Virol. 2005. PMID: 15994765 Free PMC article.
Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guérin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity.
Ami Y, Izumi Y, Matsuo K, Someya K, Kanekiyo M, Horibata S, Yoshino N, Sakai K, Shinohara K, Matsumoto S, Yamada T, Yamazaki S, Yamamoto N, Honda M. Ami Y, et al. Among authors: matsumoto s. J Virol. 2005 Oct;79(20):12871-9. doi: 10.1128/JVI.79.20.12871-12879.2005. J Virol. 2005. PMID: 16188989 Free PMC article.
Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice.
Fujii J, Naito M, Yutsudo T, Matsumoto S, Heatherly DP, Yamada T, Kobayashi H, Yoshida S, Obrig T. Fujii J, et al. Among authors: matsumoto s. Clin Vaccine Immunol. 2012 Dec;19(12):1932-7. doi: 10.1128/CVI.00473-12. Epub 2012 Oct 3. Clin Vaccine Immunol. 2012. PMID: 23035176 Free PMC article.
Evaluation of a booster tuberculosis vaccine containing mycobacterial DNA-binding protein 1 and CpG oligodeoxynucleotide G9.1 using a Guinea pig model that elicits immunity to Bacillus Calmette-Guérin.
Maeyama JI, Iho S, Suzuki F, Hayashi D, Yamamoto T, Yamazaki T, Goto Y, Ozeki Y, Matsumoto S, Yamamoto S. Maeyama JI, et al. Among authors: matsumoto s. Tuberculosis (Edinb). 2021 May;128:102067. doi: 10.1016/j.tube.2021.102067. Epub 2021 Mar 4. Tuberculosis (Edinb). 2021. PMID: 33752142
Longitudinal Evaluation of Humoral Immunity and Bacterial and Clinical Parameters Reveals That Antigen-Specific Antibodies Suppress Inflammatory Responses in Active Tuberculosis Patients.
Niki M, Yoshiyama T, Miyamoto Y, Okumura M, Niki M, Oinuma KI, Kaneko Y, Matsumoto S, Sasaki Y, Ogata H, Goto H, Kudoh S, Hoshino Y. Niki M, et al. Among authors: matsumoto s. J Immunol Res. 2018 Jul 4;2018:4928757. doi: 10.1155/2018/4928757. eCollection 2018. J Immunol Res. 2018. PMID: 30069487 Free PMC article.
5,806 results